MAM
KDNY
Marquette Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-22,000
| Closed | -$845K | – | 319 |
|
|
2023
Q2 | $845K | Hold |
22,000
| – | – | 0.21% | 32 |
|
|
2023
Q1 | $509K | Hold |
22,000
| – | – | 0.14% | 42 |
|
|
2022
Q4 | $576K | Sell |
22,000
-10,000
| -31% | -$262K | 0.17% | 38 |
|
|
2022
Q3 | $629K | Sell |
32,000
-6,000
| -16% | -$118K | 0.2% | 34 |
|
|
2022
Q2 | $665K | Buy |
38,000
+2,500
| +7% | +$43.8K | 0.19% | 45 |
|
|
2022
Q1 | $581K | Buy |
35,500
+16,261
| +85% | +$266K | 0.14% | 56 |
|
|
2021
Q4 | $314K | Hold |
19,239
| – | – | 0.07% | 76 |
|
|
2021
Q3 | $245K | Hold |
19,239
| – | – | 0.06% | 84 |
|
|
2021
Q2 | $272K | Sell |
19,239
-6,000
| -24% | -$84.8K | 0.06% | 75 |
|
|
2021
Q1 | $392K | Sell |
25,239
-156,797
| -86% | -$2.44M | 0.09% | 56 |
|
|
2020
Q4 | $2.89M | Buy |
+182,036
| New | +$2.89M | 0.67% | 26 |
|
|
2016
Q1 | – | Sell |
-350,000
| Closed | -$9.85M | – | 90 |
|
|
2015
Q4 | $9.85M | Buy |
+350,000
| New | +$9.85M | 4.01% | 6 |
|